Sector News

Shire tops US reputation survey

June 19, 2015
Life sciences
Shire has been named the most reputable pharma company in the US in a new report from the Reputation Institute
 
The report used over 50,000 consumer rankings to measure the public’s perception of pharma firms based on seven dimensions: innovation, leadership, governance, citizenship, workplace, performance, and products and services. This was then translated into a ‘RepTrack’ score.
 
Shire came out on top­ with a score of 77.55. Sanofi, Bayer and Boerhinger Ingelheim were close behind with scores of 76, 75, and 74 respectively. The top five was rounded off by generics firm Perrigo, while AbbVie, Roche, Lilly, Novartis and Takeda filled out the top 10.
 
They key drivers behind a firm’s reputation score were whether it offers high quality products, whether it is an ethical and transparent company, and whether it is a good corporate citizen.
 
The survey also found that 60% of people’s decision to buy, recommend or invest in a company depends on its reputation, and that 54% of consumers would give reputable companies the benefit of a doubt in a crisis compared with only 20% for companies with a poor reputation.
 
A UK PatientView survey released this month also placed Sanofi highly for reputation among patients, with the French firm ranking first for its pricing strategies and innovative products.
 
But there were noticeable differences in the other results between the two surveys – for example, the rest of PatientView’s top five consisted of Pfizer, Roche, GSK and Novartis.
 
By George Underwood
 
 

Related News

April 17, 2021

Thermo Fisher to buy research contractor PPD in $17B deal

Life sciences

Thermo Fisher Scientific plans to buy PPD for $17.4 billion to bolster its clinical research service offerings to pharmaceutical and biotech companies.

April 17, 2021

Nestlé finds supplement cocktail slashes preterm birth in major preconception study

Life sciences

Nestlé Research has linked a specific blend of myo-inositol (a type of sugar), probiotics, riboflavin, zinc and vitamins D, B6 and B12 to the decreased incidence of preterm birth when consumed before and during pregnancy.

April 17, 2021

Eli Lilly, riding pharma’s rising digital wave, drafts Apple exec to replace Shah as CDO

Life sciences

Eli Lilly hired a new digital chief from Apple in another consumer switch for pharma and as the industry speeds up its shift to online strategies.

Send this to a friend